The problem: probate trusts documents, not people

Estate verification has two distinct burdens. The first is attributing the decedent's instruments: confirming that the person who executed a will, funded a trust, named a beneficiary, or amended a directive was in fact the decedent and was acting without substitution or coercion. The second is verifying claimants: confirming that the individual presenting as an executor, heir, or beneficiary is the person the instrument names. Both burdens are today discharged almost entirely through documents (notarization, witness attestation, certified copies, government identification) and every one of those documents is an artifact that can be forged, procured under undue influence, or contested years after the fact when the only person who could resolve the dispute is deceased.

This is the structural weakness contested probate exploits. A late amendment executed during cognitive decline, a beneficiary designation changed under coercion, a forged holographic codicil, an impostor claimant in an intestate estate: each attacks the gap between the document and the person. Static identity verification cannot close that gap because it produces a binary match against a credential that the decedent can no longer present and that, once stolen or replicated, can be replayed indefinitely.

The inventive step this draws on

This application is rooted in the Biological Identity layer disclosed in United States Patent Application 19/647,395 (Chapter 9). The relevant inventive move is the replacement of template matching with continuity validation. Rather than enrolling a fixed biometric template and comparing later samples against it, each identity resolution event produces a biological hash: a non-invertible, domain-scoped, temporally bound representation of the subject's biological and behavioral signal state at the moment of the event. The hash is not compared against a stored template. It is evaluated for continuity with the sequence of prior validated hashes in the identity chain. The governing question is not "does this sample match an enrolled template?" but "is this sample a plausible continuation of the trajectory established by the prior validated sequence?"

The trust slope is the measure of the rate and direction of change across that sequence. An identity is therefore an accumulated slope, not a record on file. This matters for estate work in three concrete ways drawn directly from the disclosure:

  • A stolen biological hash is useless, because the hash is temporally bound and the chain requires the next valid successor, not a repeat of a prior sample. Replay fails because a replayed sample does not advance the temporal sequence.
  • Physiological drift is accommodated by construction. Continuity is measured against the recent trajectory, not against a fixed enrollment point, so an estate plan executed over decades of aging still resolves to a single coherent chain.
  • The privacy posture is preserved: no raw biological data is stored and no biometric templates are retained. What persists is the chain of non-invertible hashes and the slope computed over it, which is what a probate court actually needs to audit.

The application also composes with sibling inventions in the same portfolio. Quorum recovery (Chapter 9) supplies the multi-party reconstruction primitive used here for posthumous and incapacity scenarios; privacy-governed disclosure scopes what any single party can see; and the platform's compositional binding lets a policy require, for example, that a will execution event be authorized by a biological identity continuity check together with an attested device identity.

How estate verification maps onto the layer

Lifetime instrument anchoring. Each time the testator executes or amends an instrument, the execution event is bound to the testator's biological identity chain by recording a biological hash at the moment of signing. The instrument is anchored not to a notary's seal alone but to a point on a continuous, non-invertible trajectory. A later challenge that the testator did not execute the amendment, or executed it during substitution, is answered by asking whether the recorded hash was a valid continuation of the established chain. A forged late codicil has no valid predecessor in the chain and fails continuity; a genuine one sits on the slope.

Capacity and coercion signal, kept strictly non-diagnostic. The disclosed state inference is explicitly non-diagnostic. The layer does not, and in this application must not, produce a medical capacity determination, a mental-health assessment, or any clinical finding. What it can record is a continuity observation: that an execution event sits on or departs from the subject's established behavioral trajectory. That observation is evidence for a fact-finder, like a witness account, not a substitute for the legal capacity standard. Preserving this boundary is what keeps the application a faithful implementation of the disclosure rather than an invented capability.

Claimant resolution after death. When an heir or executor presents, the layer resolves them through the disclosed resolution modes. One-to-one resolution confirms a named beneficiary against their own established chain. One-to-many resolution screens a claimant against a set of known identities, useful where an estate must distinguish among several potential heirs. Hybrid resolution combines both, for example confirming a claimed identity while also screening for a known impostor pattern. Cross-modal fusion lets the resolution draw on multiple behavioral and biological modalities so that no single forgeable channel governs the outcome.

Posthumous continuity through quorum recovery. The decedent can no longer present, so the chain cannot be extended, but it can still be validated and, where the estate plan provided for it, reconstructed. The quorum recovery primitive allows a designated quorum (co-trustees, named fiduciaries, or a court-appointed panel) to jointly reconstruct authority over the decedent's identity records without any single party holding unilateral control. This is the mechanism for releasing sealed beneficiary designations, validating a contested execution event against the archived chain, or authorizing distribution, with privacy-governed disclosure ensuring each participant sees only what their role permits.

Deployment options and embodiments

The application supports a range of deployment configurations rather than a single instance:

  • Estate planning capture. Integrated at the drafting and execution stage, where each signing event is anchored as the plan is built, producing the strongest chain because it begins during the testator's lifetime.
  • Probate registry integration. Deployed at the court or registrar, where claimant resolution and quorum recovery run at the point of admission to probate, leaving an auditable record in the estate file.
  • Fiduciary and trustee administration. Used by trustees administering ongoing trusts to re-resolve beneficiaries at each distribution event, defeating impersonation across the multi-year life of a trust.
  • Cross-border and tax compliance. Where FATCA and equivalent regimes require beneficiary identity assurance, the continuity chain supplies a verifiable basis that does not depend on retained biometric templates, aligning with GDPR data-minimization expectations because no raw biological data is stored.
  • Assurance tiers via compositional binding. Configurations range from a single-substrate behavioral continuity check to high-assurance multi-substrate binding (biological identity plus attested device identity plus a validated agent), set by policy to match the value and contestability of the estate.

Across all of these, the recurring object a court receives is the same: an auditable chain of temporally bound, non-invertible observations and the trust slope computed over them, rather than a pile of documents whose only guarantee is that they exist.

What this application does not claim

To stay within the disclosure, the layer here makes no diagnostic determination of any kind: no capacity ruling, no mental-health assessment, no impairment finding. It stores no raw biometric data and retains no template. It does not assert accuracy figures or benchmarks, which the underlying disclosure does not provide. The legal standards for testamentary capacity, undue influence, and standing remain with the court; the layer supplies grounded, auditable identity evidence, not a verdict.

Disclosure Scope

The biological identity technology described in this article is disclosed in United States Patent Application 19/647,395. The estate verification domain framing, deployment scenarios, and beneficiary classes described here are applications of that disclosed technology and are presented as an enabling, dated public disclosure of how the claimed inventions apply to estate and probate verification. No accuracy figures, benchmarks, or mechanisms beyond those in the cited application are claimed.